InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-3.2%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Ford Robert B, Chairman & CEO. Officer active across 1 company, notably Abbott Laboratories. Cumulatively, 15 disclosures have been published. History available since 25 June 2021. The latest transaction was filed on 27 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations15 total
30,308 shares@ US$116.268.7% of flowCommon shares without par valueSEC:0001612571-26-000006:0
31,651 shares@ US$135.8712.1% of flowCommon shares without par valueSEC:0001415889-25-006755:0
64,897 shares0Common shares without par valueSEC:0001415889-25-005891:0
285,388 shares@ US$38.4030.9% of flowCommon shares without par valueSEC:0001415889-25-003394:0
127,436 shares@ US$47.0015.8% of flowCommon shares without par valueSEC:0001415889-24-023389:0
31,610 shares@ US$120.0510.2% of flowCommon shares without par valueSEC:0001415889-24-006406:0
70,332 shares0Common shares without par valueSEC:0001415889-24-005088:0
30,742 shares@ US$99.778.5% of flowCommon shares without par valueSEC:0001415889-23-003904:0
70,008 shares0Common shares without par valueSEC:0001415889-23-003051:0
45,492 shares@ US$39.125.2% of flowCommon shares without par valueSEC:0001415889-22-009126:0
33,414 shares0Common shares without par valueSEC:0001415889-22-003603:0
26,579 shares@ US$122.410.0013% mcap100.0% of flowCommon shares without par valueSEC:0001415889-22-002191:0
73,992 shares0Common shares without par valueSEC:0001415889-22-001735:0
28,746 shares0Common shares without par valueSEC:0001415889-21-003428
28,746 shares0Common shares without par valueSEC:0001415889-21-003428:0
15 of 15 declarations
About Ford Robert B
Robert B. Ford is the President and CEO of Abbott Laboratories. He leads the company in its global operations, focusing on innovation and growth. His leadership is essential in maintaining Abbott's position as a leader in the healthcare sector.
